Open Access1216-P: The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program
Author(s) -
Jingwei Li,
Sunil V. Badve,
Zien Zhou,
Richard Oh,
Mary Lee,
Vlado Perkovic,
Dick de Zeeuw,
Kenneth W. Mahaffey,
Greg Fulcher,
David R. Matthews,
Bruce Neal
Publication year - 2019
Publication title -
diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.219
H-Index - 330
eISSN - 1939-327X
pISSN - 0012-1797
DOI - 10.2337/db19-1216-p
Subject(s) - canagliflozin , gout , hyperuricemia , medicine , placebo , endocrinology , hyperuricosuria , adverse effect , uric acid , type 2 diabetes , diabetes mellitus , gastroenterology , urine , alternative medicine , hypercalciuria , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom